These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 21610)

  • 1. Hepatotoxicity of erythromycin estolate during pregnancy.
    McCormack WM; George H; Donner A; Kodgis LF; Alpert S; Lowe EW; Kass EH
    Antimicrob Agents Chemother; 1977 Nov; 12(5):630-5. PubMed ID: 21610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect on birth weight of erythromycin treatment of pregnant women.
    McCormack WM; Rosner B; Lee YH; Munoz A; Charles D; Kass EH
    Obstet Gynecol; 1987 Feb; 69(2):202-7. PubMed ID: 3543767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatotoxicity to both erythromycin estolate and erythromycin ethylsuccinate.
    Keeffe EB; Reis TC; Berland JE
    Dig Dis Sci; 1982 Aug; 27(8):701-4. PubMed ID: 6980110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effect of Livex, a herbal formulation against erythromycin estolate induced hepatotoxicity in rats.
    Venkateswaran S; Pari L; Viswanathan P; Menon VP
    J Ethnopharmacol; 1997 Aug; 57(3):161-7. PubMed ID: 9292408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective role of tetrahydrocurcumin against erythromycin estolate-induced hepatotoxicity.
    Pari L; Murugan P
    Pharmacol Res; 2004 May; 49(5):481-6. PubMed ID: 14998559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythromycin estolate hepatotoxicity.
    Lloyd-Still JD; Sherman JO; Boggs J; Demers LM
    Am J Dis Child; 1978 Mar; 132(3):320. PubMed ID: 629252
    [No Abstract]   [Full Text] [Related]  

  • 7. Erythromycin jaundice: diagnosis by an in vitro challenge test.
    Cooksley WG; Powell LW
    Aust N Z J Med; 1977 Jun; 7(3):291-3. PubMed ID: 269690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytotoxic effects of erythromycin estolate and chlorpromazine on hepatocytes isolated from rats of varying ages: a brief note.
    Abernathy CO; Lukacs L; Zimmerman HJ
    Mech Ageing Dev; 1980 Jan; 12(1):1-6. PubMed ID: 7354660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Case study: Drug interference in clinical chemistry.
    Hansen JL; Swanson LN
    Am J Med Technol; 1981 Mar; 47(3):189-91. PubMed ID: 7223765
    [No Abstract]   [Full Text] [Related]  

  • 10. Erythromycin estolate and jaundice.
    Inman WH; Rawson NS
    Br Med J (Clin Res Ed); 1983 Jun; 286(6382):1954-5. PubMed ID: 6407653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythromycin propionate and estolate.
    Farre M
    Lancet; 1988 Jul; 2(8601):45. PubMed ID: 2898648
    [No Abstract]   [Full Text] [Related]  

  • 12. Erythromycin estolate-induced hepatitis. Ultrastructural study of liver.
    Gafter U; Mandel EM; Weiss S; Djaldetti M
    N Y State J Med; 1979 Jan; 79(1):87-9. PubMed ID: 282477
    [No Abstract]   [Full Text] [Related]  

  • 13. Risk-benefit equation for erythromycin estolate.
    LeBel M
    Am J Hosp Pharm; 1980 Feb; 37(2):176, 180. PubMed ID: 7361788
    [No Abstract]   [Full Text] [Related]  

  • 14. [Cholestatic hepatitis caused by erythromycin estolate].
    García Monzón C; Noguerado A; Hidalgo S; Escudero V
    Rev Clin Esp; 1985 Nov; 177(8):420-1. PubMed ID: 3836470
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hepatocellular jaundice due to erythromycin estolate].
    Zlotnick A
    Harefuah; 1978 Aug; 95(3-4):127-8. PubMed ID: 700498
    [No Abstract]   [Full Text] [Related]  

  • 16. Hepatic safety of erythromycin acistrate in 1549 patients with respiratory tract or skin infections.
    Lehtonen L; Lankinen KS; Wikberg R; Rita H; Salmi HA; Valtonen V
    J Antimicrob Chemother; 1991 Feb; 27(2):233-42. PubMed ID: 1676027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonantibiotic effects of macrolide antibiotics of the oleandomycin-erythromycin group with special reference to their "steroid-sparing" effects.
    Selenke WM; Leung GW; Townley RG
    J Allergy Clin Immunol; 1980 Jun; 65(6):454-64. PubMed ID: 6966289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of erythromycin base and estolate in gonococcal urethritis.
    Brown ST; Pedersen HB; Holmes KK
    JAMA; 1977 Sep; 238(13):1371-3. PubMed ID: 408522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FDA begins proceedings to remove erythromycin estolate from market.
    FDA Drug Bull; 1979 Nov; 9(5):26-7. PubMed ID: 510836
    [No Abstract]   [Full Text] [Related]  

  • 20. Erythromycin estolate impairs the mitochondrial and microsomal calcium homeostasis: correlation with hepatotoxicity.
    Richelmi P; Baldi C; Manzo L; Berte F; Martino AP; Mirabelli F; Bellomo G
    Arch Toxicol Suppl; 1984; 7():298-302. PubMed ID: 6595996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.